Insider · CIK 0001718020

SANDERS MACHELLE

Reports to the SEC for 4 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001718020

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	FTREFortrea Holdings Inc.S Sale	Director	SSale	−9,700 sh	$18.01	−$175K	36,399
2026-06-11	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+15.3K sh	—	—	45,936
2026-06-11	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+33.5K sh	—	—	33,540
2026-06-10	FTREFortrea Holdings Inc.M Exercise/Conversion	Director	MExercise/Conversion	+38.8K sh	—	—	46,099
2026-06-10	FTREFortrea Holdings Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−38.8K sh	—	—	0
2026-06-10	FTREFortrea Holdings Inc. · Restricted Stock UnitA Award	Director	AAward	+12.9K sh	—	—	12,852
2025-11-13	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−9,600 sh	$7.14	−$68.5K	30,642
2025-06-12	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+12.5K sh	—	—	40,242
2025-06-12	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+27.2K sh	—	—	27,181
2025-06-10	FTREFortrea Holdings Inc. · Restricted Stock UnitA Award	Director	AAward	+38.8K sh	—	—	38,817
2025-05-14	FTREFortrea Holdings Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,282 sh	—	—	7,282
2025-05-14	FTREFortrea Holdings Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−7,282 sh	—	—	0
2024-06-17	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−4,689 sh	$6.00	−$28.1K	27,742
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+6,820 sh	—	—	32,431
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+49.9K sh	—	—	49,933
2024-05-14	FTREFortrea Holdings Inc. · Restricted Stock UnitA Award	Director	AAward	+7,282 sh	—	—	7,282
2023-06-27	NVN Liquidation, Inc.S Sale	Director	SSale	−11.6K sh	$0.41	−$4,715.935	25,248
2023-06-15	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−4,000 sh	$7.98	−$31.9K	25,611
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+16.7K sh	—	—	29,611
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+39.1K sh	—	—	39,072
2023-06-07	NVN Liquidation, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+36.1K sh	—	—	36,801
2023-06-07	NVN Liquidation, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−36.1K sh	—	—	0
2023-06-06	NVN Liquidation, Inc.Restricted Stock UnitsA Award	Director	AAward	+103K sh	—	—	103,092
2022-08-15	Radius Health, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	$10.00	−$55K	0
2022-08-15	Radius Health, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$3.60	−$36K	0
2022-06-07	NVN Liquidation, Inc.Restricted Stock UnitsA Award	Director	AAward	+36.1K sh	—	—	36,101
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+12.9K sh	—	—	12,866
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+30K sh	—	—	30,022
2022-02-08	BCRXBIOCRYST PHARMACEUTICALS INC · Non-Qualified Stock OptionA Award	Director	AAward	+26.7K sh	—	—	26,667
2022-01-14	Radius Health, Inc.A Award	Director	AAward	+5,500 sh	—	—	5,500
2022-01-14	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-05-26	NVN Liquidation, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+8,923 sh	—	—	8,923
2021-05-04	NVN Liquidation, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2021-01-04	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-07-28	NVN Liquidation, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-03-03	NVN Liquidation, Inc.P Purchase	Director	PPurchase	+7,000 sh	—	—	7,000
2020-03-03	NVN Liquidation, Inc.Warrant (Right to Buy)P Purchase	Director	PPurchase	+7,000 sh	—	—	7,000
2019-07-31	NVN Liquidation, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-06-04	NVN Liquidation, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-09-24	NVN Liquidation, Inc.Stock Option (right to buy)A Award	Director	AAward	+19.2K sh	—	—	19,240

Recent filings

Accepted (ET)
Aug 54
SANDERS MACHELLE0001965040-26-000111
SEC(opens sec.gov)
Jun 154
SANDERS MACHELLE0000882796-26-000043
SEC(opens sec.gov)
Jun 124
SANDERS MACHELLE0001965040-26-000086
SEC(opens sec.gov)
Nov 174
SANDERS MACHELLE0000882796-25-000017
SEC(opens sec.gov)
Jun 164
SANDERS MACHELLE0001171843-25-003918
SEC(opens sec.gov)
Jun 124
SANDERS MACHELLE0001127602-25-017404
SEC(opens sec.gov)
May 164
SANDERS MACHELLE0001127602-25-014734
SEC(opens sec.gov)
Jun 174
SANDERS MACHELLE0001127602-24-018846
SEC(opens sec.gov)
Jun 144
SANDERS MACHELLE0001127602-24-018737
SEC(opens sec.gov)
May 164
SANDERS MACHELLE0001127602-24-015696
SEC(opens sec.gov)
Jun 274
SANDERS MACHELLE0001467154-23-000073
SEC(opens sec.gov)
Jun 154
SANDERS MACHELLE0001127602-23-018783
SEC(opens sec.gov)

Companies

Address

8 MOORE DR

DURHAM, NC, 27713